The following pages link to Breakthrough therapy
External toolsShowing 50 items.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- MDMA (links | edit)
- Gene therapy (links | edit)
- Psilocybin (links | edit)
- Alopecia areata (links | edit)
- Genentech (links | edit)
- Psychedelic therapy (links | edit)
- Amgen (links | edit)
- Arguments for and against drug prohibition (links | edit)
- Omalizumab (links | edit)
- Cancer immunotherapy (links | edit)
- Peanut allergy (links | edit)
- Mitomycin C (links | edit)
- Amikacin (links | edit)
- Treatment-resistant depression (links | edit)
- Amifampridine (links | edit)
- Tafenoquine (links | edit)
- Ocrelizumab (links | edit)
- Allopregnanolone (links | edit)
- Rand Paul (links | edit)
- Fast track (FDA) (links | edit)
- Esketamine (links | edit)
- Triple-negative breast cancer (links | edit)
- Lonafarnib (links | edit)
- Eltrombopag (links | edit)
- Priority review (links | edit)
- Elotuzumab (links | edit)
- Management of depression (links | edit)
- Obinutuzumab (links | edit)
- Pitolisant (links | edit)
- Maribavir (links | edit)
- Pimavanserin (links | edit)
- CDK inhibitor (links | edit)
- Olaratumab (links | edit)
- RNA interference (links | edit)
- Trastuzumab emtansine (links | edit)
- Budesonide (links | edit)
- Ivacaftor (links | edit)
- Selumetinib (links | edit)
- Mogamulizumab (links | edit)
- Teprotumumab (links | edit)
- Daratumumab (links | edit)
- C-Met inhibitor (links | edit)
- Sofosbuvir (links | edit)
- Nivolumab (links | edit)
- Baricitinib (links | edit)
- Dupilumab (links | edit)
- Food and Drug Administration Safety and Innovation Act (links | edit)
- Ligelizumab (links | edit)
- Elafibranor (links | edit)
- Seladelpar (links | edit)